Jeena Sikho Lifecare holds 9th AGM; declares ₹4.50 dividend
Jeena Sikho Lifecare Limited held its 9th AGM on September 28, 2026. The company declared a final dividend of ₹4.50 per equity share for FY26. Key managerial personnel including the Managing Director and directors were reappointed, and new directors were appointed.
The declaration of dividend and reappointment/appointment of directors are significant corporate actions that impact the company's governance and shareholder value.
The company held its AGM, declared a dividend, and approved several appointments, indicating normal corporate functioning and shareholder returns.
Jeena Sikho Lifecare Limited held its 9th Annual General Meeting (AGM) on September 28, 2026, at 12:00 Noon IST in Zirakpur, Punjab.
The meeting commenced with the adoption of Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2026. A final dividend of ₹4.50 per equity share of face value ₹2 was declared for the same financial year.
Several key appointments and reappointments were approved. Mrs. Bhavna Grover was reappointed as a Director retiring by rotation, and also as a Whole-time Director and Key Managerial Personnel. Mr. Karan Vir Bindra was reappointed as an Independent Director, and Mr. Manish Grover was reappointed as Managing Director and Key Managerial Personnel.
Additionally, Mr. Ajay Sharma and Mrs. Sapna Singh were appointed as Non-Executive Independent Directors. Dr. Ish Sharma and Mr. Ankush Kaushal were appointed as Directors and also as Whole-Time Directors and Key Managerial Personnel.
The members also approved granting loans, guarantees, and securities to persons covered under Section 185 of the Companies Act, 2013, and approved granting loans, giving guarantees or securities, and making investments under Section 186 of the Companies Act, 2013.
The results of the voting, along with the Scrutinizer’s Report, are expected to be announced within two working days from the conclusion of the AGM. The proceedings of the AGM and related information are available on the company's website.
What to do with a filing like this
Jeena Sikho Lifecare Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Jeena Sikho Lifecare Limited. Read the original for the full detail.